Previous Page  3 / 5 Next Page
Information
Show Menu
Previous Page 3 / 5 Next Page
Page Background

Page 12

November 13-14, 2019 | London, UK

ORTHOPEDICS, OSTEOPOROSIS & TRAUMA

12

th

International Conference on

J Orthop Trauma Surg Rel Res, Volume 14

Volume: 14 | ISSN: 1897-2276

Journal of Orthopaedics Trauma Surgery and

Related Research

Orthopedics 2019

November 13-14, 2019

Regenerative non-surgical therapy in post-traumatic knee lesion of the medial

collateral ligament using a natural regenerative solution (Prolotherapy)

P

rolotherapy is a non-surgical injection therapy in regeneration medicine. Any acute trauma to the knee ligaments in the acute

phase need rest and immobilization. The healing curve can improve dramatically using Prolotherapy. All weak ligaments in

the chronic healing face may not heal well and cause a secondary weak joint. This can become a chronic pain syndrome because

there is a less functional knee joint. Prolotherapy to the damaged connective tissue can accelerate healing and blood supply to

regenerate the damaged tissue and increase the joint function. The objective in

this presentation is to show how important it is to understand why joints become

degenerative caused by weak ligaments and howwe can correct this degenerative

process by treating the connective tissues to strengthen the ligaments. The

ligaments are the structure that have been forgotten and are so important in joint

stability. Once the ligaments are treated with prolotherapy injection therapy

using dextrose, the bio-tensegrity of the joint will function better. In conclusion,

prolotherapy is a very safe, effective and easy treatment to improve the joint

function, reduce pain, avoid surgery and to give the patient a better quality of life.

Biography

Stephen Cavallino have been Board Certified in Emergency Medicine in Italy. He has been involved in regenerative medicine for more than

20 years. He is now the Director of the European School of Prolotherapy in Italy. He has participated in many different voluntary Prolotherapy

Missions worldwide. He is a member of the Hackett Hemwall Patterson Foundation (HHPF) in Wisconsin, USA and Vice-President of

the Italian Association of Prolotherapy (SIPRO) since 2003. Prolotherapy has grown now throughout Europe because he dedicated many

years of teaching prolotherapy with the help of many clinical instructors from the SIPRO and HHPF. Currently, he is a Clinical Instructor for

Prolotherapy and Neuroprolotherapy (Perineural Injection Treatment).

s.cavallino@gmail.com

Stephen Cavallino

European School of Prolotherapy, Italy